23andMe, the pioneer of at-home DNA testing, is now facing a financial cliff that could redefine data privacy in the genetic age. Once valued at $6 billion, the company has been hit by plummeting stock prices, a massive data breach affecting millions, and a mass resignation of its board. With the specter of bankruptcy looming, the fate of 15 million users' genetic data hangs in … [Read more...] about 23andMe’s Financial Cliff: What Happens to Your DNA Data?